← back to search

Mathias T. Rosenfeldt

University of Würzburg · DE
Area of research
Molecular Biology · Physiology
Research interest
Research interests include Telomeres, Telomerase, and Senescence, Extracellular vesicles in disease, Ubiquitin and proteasome pathways, and RNA modifications and cancer.
h-index
25
citations
5,909
works
152
NIH funding
primary concept
email

Recent publications

Extrachromosomal DNA–Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in <i>MYCN</i> -Amplified Cancers
Cancer Discovery 2025cited by 8position: middledoi
USP10 drives cancer stemness and enables super-competitor signalling in colorectal cancer
Oncogene 2024cited by 15position: middledoi
USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancer
Cell Death and Differentiation 2023cited by 32position: middledoi
Stabilisation of β-Catenin-WNT signalling by USP10 in APC- <i>truncated</i> colorectal cancer drives cancer stemness and enables super-competitor signalling
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 1position: middledoi
The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming
Cell Metabolism 2022cited by 232position: middledoi
Diabetes Mellitus Is a Possible Risk Factor for Nodo-paranodopathy With Antiparanodal Autoantibodies
Neurology Neuroimmunology & Neuroinflammation 2022cited by 17position: middledoi
Acute systemic knockdown of <i>Atg7</i> is lethal and causes pancreatic destruction in shRNA transgenic mice
Autophagy 2022cited by 7position: lastdoi
MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer
Nature Communications 2021cited by 73position: middledoi
LXRα activation and Raf inhibition trigger lethal lipotoxicity in liver cancer
Nature Cancer 2021cited by 59position: middledoi
Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen‐activated protein kinase pathway
British Journal of Dermatology 2021cited by 4position: middledoi
LUBAC determines chemotherapy resistance in squamous cell lung cancer
The Journal of Experimental Medicine 2019cited by 99position: middledoi
Senescence Sensitivity of Breast Cancer Cells Is Defined by Positive Feedback Loop between CIP2A and E2F1
Cancer Discovery 2013cited by 134position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 3 papers (2021–2023)Markus E. Diefenbacher · Helmholtz Zentrum München3 papers (2019–2023)Almut Schulze · German Cancer Research Center3 papers (2021–2023)Markus Eckstein · Centro de Investigación del Cáncer2 papers (2021–2022)Charis Kalogirou · National Center for Tumor Diseases2 papers (2021–2022) · 2 papers (2019–2023)Elena Hartmann · University of Würzburg2 papers (2021–2022) · 2 papers (2021–2023) · 2 papers (2021–2022) · 1 papers (2021–2021) · 1 papers (2022–2022)Johannes Dorst · Johannes Gutenberg University Mainz1 papers (2022–2022) · 1 papers (2022–2022)Dominic Grün · Max Delbrück Center1 papers (2022–2022)Ilya Ayzenberg · St. Josef-Hospital1 papers (2022–2022)Marteinn T. Snaebjornsson · German Cancer Research Center1 papers (2021–2021) · 1 papers (2021–2021)M. Weihrauch · Johannes Gutenberg University Mainz1 papers (2022–2022)Heikki Joensuu · Eötvös Loránd University1 papers (2013–2013)Alexander Grimm · Johannes Gutenberg University Mainz1 papers (2022–2022)